Evolution of liver transplantation in Europe: Report of the European Liver Transplant Registry, Liver Transplantation, vol.75, issue.12, pp.1231-1243, 2003. ,
DOI : 10.1016/j.lts.2003.09.018
Current Status and Future of Liver Transplantation, Seminars in Liver Disease, vol.30, issue.04, pp.411-421, 2010. ,
DOI : 10.1055/s-0030-1267541
A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease, Kidney International, vol.85, issue.5, pp.1200-1207, 2014. ,
DOI : 10.1038/ki.2013.455
Hepatitis C and its impact on renal transplantation, Nature Reviews Nephrology, vol.10, issue.3, pp.172-182, 2015. ,
DOI : 10.1111/j.1600-6143.2010.03091.x
Natural History of Clinically Compensated Hepatitis C Virus???Related Graft Cirrhosis After Liver Transplantation, Hepatology, vol.3, issue.4, pp.852-858, 2000. ,
DOI : 10.1053/jhep.2000.17924
The natural history of recurrent hepatitis C and what influences this, Liver Transplantation, vol.6, issue.suppl 1, pp.36-44, 2008. ,
DOI : 10.1053/jhep.1997.v25.pm0008985291
The association between hepatitis C infection and survival after orthotopic liver transplantation, Gastroenterology, vol.122, issue.4, pp.889-896, 2002. ,
DOI : 10.1053/gast.2002.32418
Hepatitis C and kidney disease: An overview and approach to management, World Journal of Hepatology, vol.7, issue.1, pp.78-92, 2015. ,
DOI : 10.1111/ajt.12209
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295197/pdf
Hepatitis C virus infection in dialysis and renal transplantation, Kidney International, vol.51, issue.4, pp.981-999, 1997. ,
DOI : 10.1038/ki.1997.139
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience, Journal of Hepatology, vol.60, issue.1, pp.78-86, 2014. ,
DOI : 10.1016/j.jhep.2013.08.018
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation, Clinical Gastroenterology and Hepatology, vol.13, issue.11, 1993. ,
DOI : 10.1016/j.cgh.2015.05.030
URL : https://hal.archives-ouvertes.fr/hal-01162384
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence ??? The ANRS CUPILT study, Journal of Hepatology, vol.65, issue.4, pp.711-718, 2016. ,
DOI : 10.1016/j.jhep.2016.05.039
URL : https://hal.archives-ouvertes.fr/hal-01395132
Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents, American Journal of Transplantation, vol.386, issue.5 ,
DOI : 10.1016/S0140-6736(15)00349-9
Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation, American Journal of Transplantation, vol.18, issue.5, pp.1474-1479, 2015. ,
DOI : 10.1053/j.ajkd.2003.09.019
DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting, Transplant International, vol.36, issue.Suppl. 1, pp.999-1007, 2016. ,
DOI : 10.1111/liv.13025
An algorithm for the grading of activity in chronic hepatitis C, Hepatology, vol.24, issue.2 ,
DOI : 10.1002/hep.510240201
A more accurate Accepted Article Table 2: Antiviral therapy regimens, Regimen SOF+DCV SOF+DCV+RBV SOF+RBV SOF+PEG+RBV SOF+LEDI SOF+LEDI+RBV SOF+SIM, vol.8 ,